Comments: TN HB2002 | 2017-2018 | 110th General Assembly
Bill Title: As enacted, permits the direct administration of buprenorphine mono or buprenorphine without the use of naloxone as a treatment for substance use disorder under certain circumstances. - Amends TCA Title 53, Chapter 10; Title 53, Chapter 11 and Title 63.
Sponsorship: Moderate Partisan Bill (Republican 6-1)
Status: (Passed) 2018-04-17 - Pub. Ch. 674 [HB2002 Detail]
Text: Latest bill text (Chaptered) [PDF]
Sponsorship: Moderate Partisan Bill (Republican 6-1)
Status: (Passed) 2018-04-17 - Pub. Ch. 674 [HB2002 Detail]
Text: Latest bill text (Chaptered) [PDF]
PolitiCorps Conversations
Start PolitiCorps Debate| Title | PolitiCorps | Access | Comments | Views | Last Post |
|---|---|---|---|---|---|
| There are no visible public or private PolitiCorps discussions concerning the 2017 Tennessee HB2002 at this time. | |||||
